• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氟康唑暴露而不是克隆传播与对唑类抗真菌药物具有交叉耐药性的光滑假丝酵母菌的出现相关。

Fluconazole exposure rather than clonal spreading is correlated with the emergence of Candida glabrata with cross-resistance to triazole antifungal agents.

机构信息

Department of Internal Medicine, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University, Kaohsiung City, Taiwan; Graduate Institute of Medicine, College of Medicine,Kaohsiung Medical University, Kaohsiung City, Taiwan.

出版信息

Kaohsiung J Med Sci. 2012 Jun;28(6):306-15. doi: 10.1016/j.kjms.2011.11.011. Epub 2012 Apr 4.

DOI:10.1016/j.kjms.2011.11.011
PMID:22632885
Abstract

The emergence of antifungal resistance in Candida species has raised concern in recent years, especially resistance toward triazole. Several newer triazole antifungal agents have been introduced which have a broader spectrum for fungal infections, such as voriconazole. However, cross-resistance among triazoles is a major concern with regard to their clinical application. Antifungal susceptibility was performed using E-test for 166 clinical isolates (29 blood and 137 nonblood isolates) in 2003 and 2004. We applied pulsed-field gel electrophoresis for genotyping. Ninety isolates of C. albicans, 47 isolates of C. tropicalis, 27 isolates of C. glabrata, and two isolates of C. krusei were included. All isolates were susceptible to amphotericin B. Eleven (40.7%) of the 27 C. glabrata had intermediate resistance to caspofungin. Forty-seven (28.3%) of the 166 isolates were not susceptible to fluconazole, including two C. albicans, 16 C. tropicalis, 27 C. glabrata, and two C. krusei isolates. All except seven of the C. glabrata isolates were susceptible to voriconazole. All the triazole drugs had a positive correlation among their minimum inhibitory concentrations (MICs). Fluconazole MIC was a good predictor for susceptibility to voriconazole, as determined using a receiver operating characteristic curve. Furthermore, a high diversity of pulsotypes for the 27 clinical isolates of C. glabrata was observed. Previous fluconazole exposure within 3 months was associated with reduced triazole susceptibility for C. glabrata. We demonstrated a significant positive correlation of MIC values among the four tested triazole drugs. No amphotericin B and caspofungin resistant isolates were found in this study. The cross-resistance to triazole among C. glabrata isolates was associated with previous fluconazole exposure as opposed to clonal spreading. Selection pressure due to fluconazole use may play a major role in triazole cross-resistance.

摘要

近年来,念珠菌属真菌的抗药性问题引起了关注,尤其是对三唑类药物的抗药性。已经引入了几种新型三唑类抗真菌药物,它们对真菌感染具有更广泛的谱,例如伏立康唑。然而,三唑类药物之间的交叉耐药性是其临床应用的主要关注点。2003 年和 2004 年,我们使用 E 试验对 166 株临床分离株(29 株血液分离株和 137 株非血液分离株)进行了抗真菌药敏试验。我们应用脉冲场凝胶电泳进行基因分型。包括 90 株白念珠菌、47 株热带念珠菌、27 株光滑念珠菌和 2 株克柔念珠菌。所有分离株均对两性霉素 B 敏感。27 株光滑念珠菌中有 11 株(40.7%)对卡泊芬净呈中介耐药。166 株分离株中有 47 株(28.3%)对氟康唑不敏感,包括 2 株白念珠菌、16 株热带念珠菌、27 株光滑念珠菌和 2 株克柔念珠菌。除了 7 株光滑念珠菌外,所有分离株均对伏立康唑敏感。所有三唑类药物的最低抑菌浓度(MIC)之间存在正相关。使用受试者工作特征曲线确定,氟康唑 MIC 是预测伏立康唑敏感性的良好指标。此外,我们观察到 27 株光滑念珠菌临床分离株的脉冲场凝胶电泳带型高度多样化。在 3 个月内有氟康唑暴露史的患者,其光滑念珠菌对三唑类药物的敏感性降低。我们发现四种测试的三唑类药物之间的 MIC 值有显著的正相关。在这项研究中,没有发现耐两性霉素 B 和卡泊芬净的分离株。光滑念珠菌对三唑类药物的交叉耐药性与氟康唑暴露有关,而不是与克隆传播有关。由于氟康唑的使用而产生的选择压力可能在三唑类药物的交叉耐药性中起主要作用。

相似文献

1
Fluconazole exposure rather than clonal spreading is correlated with the emergence of Candida glabrata with cross-resistance to triazole antifungal agents.氟康唑暴露而不是克隆传播与对唑类抗真菌药物具有交叉耐药性的光滑假丝酵母菌的出现相关。
Kaohsiung J Med Sci. 2012 Jun;28(6):306-15. doi: 10.1016/j.kjms.2011.11.011. Epub 2012 Apr 4.
2
The activity of echinocandins, amphotericin B and voriconazole against fluconazole-susceptible and fluconazole-resistant Brazilian Candida glabrata isolates.棘白菌素类、两性霉素 B 和伏立康唑对氟康唑敏感和氟康唑耐药巴西光滑念珠菌分离株的活性。
Mem Inst Oswaldo Cruz. 2012 May;107(3):433-6. doi: 10.1590/s0074-02762012000300022.
3
Trends in species distribution and susceptibility of bloodstream isolates of Candida collected in Monterrey, Mexico, to seven antifungal agents: results of a 3-year (2004 to 2007) surveillance study.墨西哥蒙特雷收集的念珠菌血流分离株的物种分布及对七种抗真菌药物敏感性的趋势:一项为期三年(2004年至2007年)的监测研究结果
J Clin Microbiol. 2008 Sep;46(9):2902-5. doi: 10.1128/JCM.00937-08. Epub 2008 Jul 16.
4
[Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].念珠菌属对三唑类药物的抗真菌药敏谱:应用美国临床和实验室标准协会(CLSI)新的种特异性临床折点和流行病学截断值来表征抗真菌药物耐药性
Mikrobiyol Bul. 2016 Jan;50(1):122-32. doi: 10.5578/mb.10682.
5
Candida and candidaemia. Susceptibility and epidemiology.念珠菌与念珠菌血症。药敏性与流行病学。
Dan Med J. 2013 Nov;60(11):B4698.
6
Prevalence and Antifungal Susceptibility of the Emerging Fungal Species, , Isolated in a Teaching Hospital in Poland.在波兰的一家教学医院中分离出的新兴真菌种 的流行情况和抗真菌药敏性。
Pol J Microbiol. 2019 Sep;68(3):303-308. doi: 10.33073/pjm-2019-032. Epub 2019 Sep 3.
7
In vitro activities of voriconazole, fluconazole, itraconazole and amphotericin B against non Candida albicans yeast isolates.伏立康唑、氟康唑、伊曲康唑和两性霉素B对非白色念珠菌酵母分离株的体外活性。
Rev Iberoam Micol. 2005 Mar;22(1):24-8. doi: 10.1016/s1130-1406(05)70002-4.
8
Synergistic activities of three triazoles with caspofungin against Candida glabrata isolates determined by time-kill, Etest, and disk diffusion methods.三种三唑类药物与卡泊芬净联合对光滑念珠菌分离株的协同作用,通过时间杀伤、Etest 和纸片扩散方法确定。
Antimicrob Agents Chemother. 2010 May;54(5):2244-7. doi: 10.1128/AAC.01527-09. Epub 2010 Mar 1.
9
In vitro evaluation of antibiotic lock technique for the treatment of Candida albicans, C. glabrata, and C. tropicalis biofilms.体外评估抗生素锁技术治疗白色念珠菌、近平滑念珠菌和热带念珠菌生物膜。
J Korean Med Sci. 2010 Dec;25(12):1722-6. doi: 10.3346/jkms.2010.25.12.1722. Epub 2010 Nov 24.
10
In vitro activity of voriconazole and other antifungal agents against clinical isolates of Candida glabrata and Candida krusei.伏立康唑及其他抗真菌药物对光滑念珠菌和克柔念珠菌临床分离株的体外活性
Eur J Clin Microbiol Infect Dis. 2004 Aug;23(8):619-24. doi: 10.1007/s10096-004-1174-9. Epub 2004 Jul 16.

引用本文的文献

1
Lung microbiome: new insights into the pathogenesis of respiratory diseases.肺部微生物组:呼吸系统疾病发病机制的新见解。
Signal Transduct Target Ther. 2024 Jan 17;9(1):19. doi: 10.1038/s41392-023-01722-y.
2
Effect of a High-Intensity Laser on Colony Count.高强度激光对菌落计数的影响。
J Lasers Med Sci. 2022 Dec 7;13:e59. doi: 10.34172/jlms.2022.59. eCollection 2022.
3
The impact of COVID-19 on antimicrobial prescription and drug resistance in fungi and bacteria.新冠疫情对真菌和细菌中抗菌药物处方和耐药性的影响。

本文引用的文献

1
Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria.重新审视棘白菌素类药物和念珠菌的临床折点:整合分子、临床和微生物学数据,以制定出基于物种的解释标准。
Drug Resist Updat. 2011 Jun;14(3):164-76. doi: 10.1016/j.drup.2011.01.004. Epub 2011 Feb 24.
2
Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: time for harmonization of CLSI and EUCAST broth microdilution methods.氟康唑和念珠菌的野生型 MIC 分布、流行病学折点值和种特异性临床断点:CLSI 和 EUCAST 肉汤微量稀释方法协调的时机。
Drug Resist Updat. 2010 Dec;13(6):180-95. doi: 10.1016/j.drup.2010.09.002. Epub 2010 Nov 2.
3
Braz J Microbiol. 2022 Dec;53(4):1925-1935. doi: 10.1007/s42770-022-00818-x. Epub 2022 Sep 10.
4
Synthesis, Optimization, Antifungal Activity, Selectivity, and CYP51 Binding of New 2-Aryl-3-azolyl-1-indolyl-propan-2-ols.新型2-芳基-3-唑基-1-吲哚基-丙-2-醇的合成、优化、抗真菌活性、选择性及与CYP51的结合
Pharmaceuticals (Basel). 2020 Aug 8;13(8):186. doi: 10.3390/ph13080186.
5
Clonal Spread of Candida glabrata Bloodstream Isolates and Fluconazole Resistance Affected by Prolonged Exposure: a 12-Year Single-Center Study in Belgium.比利时 12 年单中心研究显示:光滑念珠菌血流分离株的克隆传播和氟康唑耐药性受长期暴露的影响。
Antimicrob Agents Chemother. 2018 Jul 27;62(8). doi: 10.1128/AAC.00591-18. Print 2018 Aug.
6
Synergistic Antifungal Effect of Fluconazole Combined with Licofelone against Resistant .氟康唑与利考昔芬联合使用对耐药菌的协同抗真菌作用
Front Microbiol. 2017 Nov 7;8:2101. doi: 10.3389/fmicb.2017.02101. eCollection 2017.
7
Synergistic Effect of Fluconazole and Calcium Channel Blockers against Resistant Candida albicans.氟康唑与钙通道阻滞剂对耐药白色念珠菌的协同作用。
PLoS One. 2016 Mar 17;11(3):e0150859. doi: 10.1371/journal.pone.0150859. eCollection 2016.
8
Nosocomial candidiasis in Rio de Janeiro State: Distribution and fluconazole susceptibility profile.里约热内卢州的医院内念珠菌病:分布及氟康唑药敏谱
Braz J Microbiol. 2015 Jun 1;46(2):477-84. doi: 10.1590/S1517-838246220120023. eCollection 2015 Jun.
9
The lung mycobiome: an emerging field of the human respiratory microbiome.肺部真菌组:人类呼吸道微生物组的一个新兴领域。
Front Microbiol. 2015 Feb 13;6:89. doi: 10.3389/fmicb.2015.00089. eCollection 2015.
10
Components of the calcium-calcineurin signaling pathway in fungal cells and their potential as antifungal targets.真菌细胞中钙-钙调神经磷酸酶信号通路的组成部分及其作为抗真菌靶点的潜力。
Eukaryot Cell. 2015 Apr;14(4):324-34. doi: 10.1128/EC.00271-14. Epub 2015 Jan 30.
Risk factors for fluconazole resistance in patients with Candida glabrata bloodstream infection: potential impact of control group selection on characterizing the association between previous fluconazole use and fluconazole resistance.光滑念珠菌血流感染患者中氟康唑耐药的危险因素:对照组选择对描述氟康唑使用与氟康唑耐药之间关联的潜在影响。
Am J Infect Control. 2010 Aug;38(6):456-60. doi: 10.1016/j.ajic.2009.12.011. Epub 2010 Apr 3.
4
Two closely related fluconazole-resistant Candida tropicalis clones circulating in Taiwan from 1999 to 2006.1999年至2006年期间,两种密切相关的耐氟康唑热带假丝酵母菌克隆株在台湾地区传播。
Microb Drug Resist. 2009 Sep;15(3):205-10. doi: 10.1089/mdr.2009.0915.
5
Invasive candidiasis: an overview from Taiwan.侵袭性念珠菌病:来自台湾的概述。
J Formos Med Assoc. 2009 Jun;108(6):443-51. doi: 10.1016/S0929-6646(09)60091-7.
6
Risk factors for fluconazole-resistant Candida glabrata bloodstream infections.氟康唑耐药光滑念珠菌血流感染的危险因素。
Arch Intern Med. 2009 Feb 23;169(4):379-83. doi: 10.1001/archinte.169.4.379.
7
Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.念珠菌病管理临床实践指南:美国传染病学会2009年更新版
Clin Infect Dis. 2009 Mar 1;48(5):503-35. doi: 10.1086/596757.
8
Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome.由光滑念珠菌引起的真菌血症,因基因表达改变而对氟康唑敏感性降低:危险因素、抗真菌治疗及转归
J Antimicrob Chemother. 2008 Dec;62(6):1379-85. doi: 10.1093/jac/dkn381. Epub 2008 Sep 8.
9
In vitro susceptibilities of invasive isolates of Candida species: rapid increase in rates of fluconazole susceptible-dose dependent Candida glabrata isolates.念珠菌属侵袭性分离株的体外药敏情况:氟康唑敏感剂量依赖性光滑念珠菌分离株的比例迅速上升。
Antimicrob Agents Chemother. 2008 Aug;52(8):2919-22. doi: 10.1128/AAC.00323-08. Epub 2008 May 5.
10
Susceptibilities to amphotericin B and fluconazole of Candida species in Taiwan Surveillance of Antimicrobial Resistance of Yeasts 2006.2006年台湾地区酵母抗微生物药物耐药性监测中念珠菌属对两性霉素B和氟康唑的敏感性
Diagn Microbiol Infect Dis. 2008 Jun;61(2):175-80. doi: 10.1016/j.diagmicrobio.2008.01.011. Epub 2008 Mar 4.